Uridine Triacetate (Vistogard) - Oncology Nurse Advisor

Uridine Triacetate (Vistogard)

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews uridine triacetate (Vistogard), indicated for the emergency treatment of patients following a fluorouracil (5-FU) or capecitabine overdose, or in cases of early onset, severe, or life-threatening toxicity affecting the cardiac or central nervous system, and/or early onset, unusually severe adverse reactions within 96 hours after 5-FU or capecitabine administration.
 

Next hm-slideshow in Slides